- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Westbrook Today
By the People, for the People
IDEXX Launches Cancer Diagnostic Panel for Early Canine Lymphoma Detection in UK
The new test aims to help veterinarians identify lymphoma in dogs before advanced stages.
Apr. 1, 2026 at 8:42am
Got story updates? Submit your updates here. ›
IDEXX Laboratories, a leading provider of veterinary diagnostic tests, has announced the UK availability of a new cancer diagnostic panel designed to detect canine lymphoma in its early stages. The panel, which utilizes advanced biomarker analysis, is intended to help veterinarians identify the disease sooner and potentially improve treatment outcomes for affected dogs.
Why it matters
Early detection of canine lymphoma is crucial, as the disease can progress rapidly. This new diagnostic tool from IDEXX could enable veterinarians to catch the condition earlier and provide more effective, timely care for their canine patients.
The details
The IDEXX cancer diagnostic panel analyzes a range of biomarkers associated with lymphoma, allowing for earlier identification of the disease compared to traditional methods. The test is designed to be used as part of a routine wellness checkup, providing an additional layer of screening to supplement physical exams and other diagnostics.
- IDEXX announced the UK availability of the new cancer diagnostic panel on April 1, 2026.
The players
IDEXX Laboratories
A leading provider of veterinary diagnostic tests and services, headquartered in Westbrook, Maine.
What they’re saying
“This new cancer diagnostic panel represents an important advancement in our efforts to help veterinarians detect lymphoma earlier and provide the best possible care for their canine patients.”
— Michael J. McGinley, President and CEO, IDEXX Laboratories
The takeaway
The availability of this new early-detection cancer diagnostic panel from IDEXX in the UK market is a significant step forward in improving veterinary care and outcomes for dogs at risk of developing lymphoma, a serious and often aggressive form of cancer.
